API | prothipendyl hydrochloride

prothipendyl hydrochloride Report issue

Small molecule Experimental

AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW

PROTHIPENDYL is a neuroleptic azaphenothiazine used to treat anxiety and agitation in psychotic syndromes. It also shows strong antihistamine and anti-emetic actions. ^NCATS

Chemistry

SMILES: CN(C)CCCN1c2ccccc2Sc3cccnc13
InChIKey: JTTAUPUMOLRVRA-UHFFFAOYSA-N
Mol. Mass: 285.42
ALogP: 3.64 Partition coefficient
ChEMBL Molecules:

prothipendyl

prothipendyl hydrochloride

More Chemistry

Pharmacology

Mechanisms of Action: Missing data
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

dominal | phrenotropin | prothipendyl | prothipendyl hcl | prothipendyl hydrochloride

Organizations (2)

Research & Development (2)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (6)

Approved Indications (1)

Anxiety

Experimental Indications - Clinical Trial Phases 1-4 (5)

Anxiety Disorders (Phase 3)

Dementia (Phase 3)

Depression (Phase 3)

Psychophysiologic Disorders (Phase 3)

Schizophrenia (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 2
# of Trial Organizations: 2

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue